Phase 2
N=45
Lidocaine Patches Prior to Intravenous Insertion
Need for Intravenous Catheter
Bottom Line
View on ClinicalTrials.gov: NCT00552695 ↗Enrolled (actual)
45
Serious AEs
0.0%
Results posted
Dec 2010
Primary outcome: Primary: Pain on Visual Analog Scale (VAS) — 18; 35 mm
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 2
- Interventions
- Lidocaine tetracaine (Device); Placebo (Device)
- Age
- Pediatric, Adult, Older Adult · 3+ yrs
- Sex
- All
- Sponsor
- Stony Brook University
- Primary completion
- Jan 2008
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Pain on Visual Analog Scale (VAS) |
18; 35 | — |
| SECONDARY Success of Intravenous (IV) Insertion |
18; 17 | — |
Summary
This study will determine whether application of a patch containing a topical anesthetic (numbing medicine) named lidocaine can reduce the pain of subsequent insertion of an intravenous catheter in Emergency Department patients.
Eligibility Criteria
Inclusion Criteria
- Age greater than or equal to 3,
- Need for non-emergent intravenous catheter
Exclusion Criteria
- Unstable patients,
- Allergy to lidocaine or tetracaine
Data sourced from ClinicalTrials.gov (NCT00552695). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.